HOPX and nasopharyngeal carcinoma: HOPX expression has been reported to be reduced at both the DNA and protein levels of oral and nasopharyngeal cancer cells, and its re-expression promoted cell proliferation and invasion and made the cells more susceptible to UV and cisplatin-induced cell death [66].